Do Wall Street Analysts Like DexCom Stock?

DexCom, Inc. (DXCM), with a market cap of $33.9 billion, is a leading medical device company specializing in continuous glucose monitoring (CGM) systems for diabetes management. Founded in 1999 and headquartered in San Diego, California, Dexcom has been at the forefront of CGM technology, transforming how people manage diabetes.

This healthcare company’s shares have substantially trailed the broader market over the past 52 weeks. DexCom has declined 34% over this time frame, while the broader S&P 500 Index ($SPX) has rallied 11.5%. However, the stock is up 10.2% on a YTD basis, compared to SPX’s marginal rise during the same time frame.